FDA Inspection 1054887 — Cooper Institute For Reproductive Hormonal Disorders, P.C.
The FDA completed an inspection of Cooper Institute For Reproductive Hormonal Disorders, P.C. on May 31, 2018 in Mount Laurel, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 31, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Mount Laurel, NJ (United States)